Marker Therapeutics Inc (MRKR)

[rfj1862]

Does anyone here have a schedule of data releases and a list of all ongoing trials, including their ClinicalTrials.gov identifiers?

I like Marker but they have not done a great job of making it easy to figure out what's going on and anticipated data releases.

One big thing is that it should be simple and patently obvious which trials they are involved in by simply searching clinicaltrials.gov for the company name and the also need to settle on some consistent terminology for their products so they are easy to find in the literature.

I want to see a slide with all ongoing investigations, planned analyses, and publication/presentation dates. The pipeline slide just isn't detailed enough.

They also need to get all of this stuff published, including the preclinical data, early patient experience, and they need to work on some review publications laying out the case for their technology.

In many ways this is an ideal investment opportunity--the technologies are impressive but the company hasn't done a great job of making the case yet, so they are flying under the radar. Hopefully this will change with Peter Hoang as the CEO.